/
•
•
Context is everything.
Detailed stories on technology startups, business and economic current affairs.
Detailed stories on technology startups, business and economic current affairs.
The rules require exporters of certain drugs to get an NOC from importing countries—a small but much-needed step to restoring India’s credibility in the global pharma market.
The Central Drugs Standard Control Organisation last month announced new rules for the export of drugs that are unapproved or banned in India. This happened just weeks after a BBC Eye documentary found that an Indian pharmaceutical company was manufacturing opioids and exporting them illegally to West Africa, where they are causing a drug addiction crisis.
The reaction to this is interesting. The Pharmaceutical Export Promotion Council (Pharmexcil), a government-authorized industry body, is seeking a review of a rule that says the export of (unapproved or banned in India) drugs will need a no-objection certificate from an authority in the …
The drugmaker’s reluctance to part with cash may have given it one of the strongest balance sheets in Indian pharma, but investors are increasingly rewarding risk takers.
The stock market has taken note of the company’s ambitious plans in the domestic market. But the path ahead is far from easy.
The food and grocery delivery company’s idea of providing prescription drugs in 10 minutes is facing resistance from traditional pharma players.
